CORTEXA
← Browse
crossrefCancers2025-10-31Cited by 1

Subtype Characterization of Ovarian Cancer Cell Lines Using Machine Learning and Network Analysis: A Pilot Study

Rama Krishna Thelagathoti, Dinesh S. Chandel, Chao Jiang, Wesley A. Tom, Gary Krzyzanowski, Appolinaire Olou, M. Rohan Fernando

Background/Objectives: Ovarian cancer is a heterogeneous malignancy with molecular subtypes that strongly influence prognosis and therapy. High-dimensional mRNA data can capture this biological diversity, but its complexity and noise limit robust subtype characterization. Furthermore, current classification approaches often fail to reflect subtype-specific transcriptional programs, underscoring the need for computational strategies that reduce dimensionality and identify discriminative molecular features. Methods: We designed a multi-stage feature selection and network analysis framework tailored for high-dimensional transcriptomic data. Starting with ~65,000 mRNA features, we applied unsupervised variance-based filtering and correlation pruning to eliminate low-information genes and reduce redundancy. The applied supervised Select-K Best filtering further refined the feature space. To enhance robustness, we implemented a hybrid selection strategy combining recursive feature elimination (RFE) with random forests and LASSO regression to identify discriminative mRNA features. Finally, these features were then used to construct a gene co-expression similarity network. Results: This pipeline reduced approximately 65,000 gene features to a subset of 83 discriminative transcripts, which were then used for network construction to reveal subtype-specific biology. The analysis identified four distinct groups. One group exhibited classical high-grade serous features defined by TP53 mutations and homologous recombination deficiency, while another was enriched for PI3K/AKT and ARID1A-associated signaling consistent with clear cell and endometrioid-like biology. A third group displayed drug resistance-associated transcriptional programs with receptor tyrosine kinase activation, and the fourth demonstrated a hybrid profile bridging serous and endometrioid expression modules. Conclusions: This pilot study shows that combining unsupervised and supervised feature selection with network modeling enables robust stratification of ovarian cancer subtypes.

View free PDFSource page

Related papers

crossrefCancers2026-04-03Cited by 1

Machine-Learning-Based Survival Prediction in Glioblastoma Using Graph-Theoretical Analysis of Structural Network Alterations

Andreas Stadlbauer, Stefan Oberndorfer, Gertraud Heinz, Franz Marhold, Thomas M. Kinfe, Mario Dorostkar, et al.

Background: Glioblastoma is an extremely aggressive brain tumor that diffusely infiltrates white matter and alters large-scale brain connectivity. Most prognostic models focus on localized tumor features and clinical variables, overlooking broader effects on the brain’s structura…

View free PDFSource page
crossrefCancers2024-09-20Cited by 22

A Novel Approach for Predicting the Survival of Colorectal Cancer Patients Using Machine Learning Techniques and Advanced Parameter Optimization Methods

Andrzej Woźniacki, Wojciech Książek, Patrycja Mrowczyk

Background: Colorectal cancer is one of the most prevalent forms of cancer and is associated with a high mortality rate. Additionally, an increasing number of adults under 50 are being diagnosed with the disease. This underscores the importance of leveraging modern technologies,…

View free PDFSource page
crossrefCancers2024-12-28Cited by 4

Machine Learning and Computed Tomography Radiomics to Predict Disease Progression to Upfront Pembrolizumab Monotherapy in Advanced Non-Small-Cell Lung Cancer: A Pilot Study

Ian Janzen, Cheryl Ho, Barbara Melosky, Qian Ye, Jessica Li, Gang Wang, et al.

Background/Objectives: Pembrolizumab monotherapy is approved in Canada for first-line treatment of advanced NSCLC with PD-L1 ≥ 50% and no EGFR/ALK aberrations. However, approximately 55% of these patients do not respond to pembrolizumab, underscoring the need for the early interv…

View free PDFSource page
crossrefCancers2022-04-15Cited by 35

Deep Neural Networks and Machine Learning Radiomics Modelling for Prediction of Relapse in Mantle Cell Lymphoma

Catharina Silvia Lisson, Christoph Gerhard Lisson, Marc Fabian Mezger, Daniel Wolf, Stefan Andreas Schmidt, Wolfgang M. Thaiss, et al.

Mantle cell lymphoma (MCL) is a rare lymphoid malignancy with a poor prognosis characterised by frequent relapse and short durations of treatment response. Most patients present with aggressive disease, but there exist indolent subtypes without the need for immediate intervention…

View free PDFSource page
crossrefCancers2024-06-28Cited by 7

Exploring Selenoprotein P in Liver Cancer: Advanced Statistical Analysis and Machine Learning Approaches

Ali Razaghi, Mikael Björnstedt

Selenoprotein P (SELENOP) acts as a crucial mediator, distributing selenium from the liver to other tissues within the body. Despite its established role in selenium metabolism, the specific functions of SELENOP in the development of liver cancer remain enigmatic. This study aims…

View free PDFSource page
crossrefCancers2025-04-11Cited by 1

Dynamic Prediction of Rectal Cancer Relapse and Mortality Using a Landmarking-Based Machine Learning Model: A Multicenter Retrospective Study from the Italian Society of Surgical Oncology—Colorectal Cancer Network Collaborative Group

Rossella Reddavid, Ugo Elmore, Jacopo Moro, Paola De Nardi, Alberto Biondi, Roberto Persiani, et al.

Background: Almost 30% of patients with rectal cancer (RC) who submit to comprehensive treatment experience relapse. Surveillance plays a leading role in early detection. The landmark approach provides a more flexible and dynamic framework for survival prediction. Objective: This…

View free PDFSource page